肾上腺偶发瘤(肾上腺瘤)鉴别诊断的逐步方法(附对欧洲内分泌学会新临床实践指南的评论)
本文通过广泛文献综述提出肾上腺偶发瘤的逐步诊断方法,并评论欧洲内分泌学会新临床实践指南。多数肿瘤为无功能良性腺瘤,最重要的影像特征是CT衰减系数,密度小于10 HU多提示富脂质良性腺瘤,大于10 HU或恶性肿瘤病史需警惕恶性。所有患者应行1 mg地塞米松试验和血浆甲氧基肾上腺素检测,有低钾血症和/或难治性高血压时测醛固酮与肾素比值。
要点
- CT密度小于10 HU多提示富脂质良性腺瘤,大于10 HU或恶性肿瘤病史需警惕恶性。
- 所有肾上腺偶发瘤患者应行1 mg地塞米松试验和血浆甲氧基肾上腺素检测。
- 有低钾血症和/或难治性高血压时测血浆醛固酮与肾素比值(ARR)。
核心结论
- CT密度小于10 HU在多数情况下为富脂质良性腺瘤的特征,大于10 HU或/和恶性肿瘤病史提示恶性可能。
- 所有患者应行1 mg地塞米松试验和血浆甲氧基肾上腺素检测,有低钾血症和/或难治性高血压时测ARR。
- 新近研究显示即使无功能且小于4 cm的肿瘤也可能增加代谢风险,因此可考虑更早阶段手术。
研究设计与样本
- 本文为广泛文献综述,检索PubMed和Google Scholar,使用Mesh词包括Adrenal、Incidentaloma、Adrenal tumours、Radiology、Diagnosis,并进行交叉引用检索,同时对欧洲内分泌学会新指南进行评论。
关键影像表现/征象
- 肾上腺偶发瘤最重要的影像学特征是辐射衰减系数(CT密度)。
- 廓清百分比和肿瘤的影像学特征可能有助于诊断。
诊断标准与关键数值
- CT密度小于10 HU在多数情况下为富脂质良性腺瘤的特征。
- CT密度大于10 HU或/和恶性肿瘤病史提示恶性可能。
临床应用与阅片要点
- 所有肾上腺偶发瘤患者应行1 mg地塞米松试验和血浆甲氧基肾上腺素检测。
- 有低钾血症和/或难治性高血压病史时,检测血浆醛固酮与肾素比值(ARR)。
- 新近研究显示即使无功能且小于4 cm的肿瘤也可能增加代谢风险,因此可考虑更早阶段手术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To present a step by step approach for the diagnosis of adrenal incidentaloma (AI).
METHOD: An extensive review of the literature was conducted, searching the Pub-Med and Google Scholar using the Mesh terms; Adrenal; Incidentaloma; Adrenal tumours; Radiology; Diagnosis. We also did a cross-referencing search of the literature. Comments on the new European guidelines are presented.
RESULTS: The majority of the tumours are non-functioning benign adenomas. The most important radiological characteristic of an adrenal incidentaloma is the radiation attenuation coefficient. Wash out percentage and the imaging characteristics of the tumour may help in diagnosis.
CONCLUSION: Density less than 10 HU is in most cases characteristic of a lipid rich benign adenoma. More than 10 HU or/and history of malignancy raise the possibility for cancer. 1 mg dexamethasone test and plasma metanephrines should be done in all patients. If there is history of hypokalemia and/or resistant hypertension we test the plasma aldosterone to plasma renin ratio (ARR). Newer studies have shown that tumours even nonfunctioning and less than 4 cm may increase the metabolic risks so we may consider surgery at an earlier stage.
引用
- Farrugia FA, Misiakos E, Martikos G, et al. A step by step approach in differential diagnosing of adrenal incidentaloma (epinephroma), (with comments on the new Clinical Practice Guidelines of the European Society of Endocrinology). Rom J Intern Med. 2017. PMID: 28672763. doi:10.1515/rjim-2017-0025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。